GeoVax appeals Nasdaq delisting notice tied to minimum bid price rule
GOVX•Company plans to present compliance plan
GeoVax plans to present a compliance plan aimed at regaining and maintaining listing standards.
Nasdaq delisting determination and appeal
GeoVax faces a Nasdaq delisting determination tied to the minimum bid price rule under Listing Rule 5550(a)(2).
A hearing before the Nasdaq Hearings Panel is scheduled for Oct. 13, 2026, following an appeal request.
The appeal stays any suspension or delisting action, and shares are expected to keep trading on Nasdaq at least through that period.
Related News
Vistra Retail EVP and President Scott A. Hudson disposes of 44,444 Vistra shares worth $6.75 million
VST•
RH Q2 FY26 GAAP net income rises 16.37% to USD 60.2 million; GAAP net revenues increase 2.6% to USD 922.2 million
RH•
